Expertise in
4
conditions

Jonathan C. Packham

Nottingham, ENG, GB 
Expertise in
4
conditions
Nottingham, ENG, GB 
OverviewLocationsClinical Research

Overview

Jonathan Packham practices in Nottingham, United Kingdom. Mr. Packham is highly rated in 4 conditions, according to our data. His top areas of expertise are Axial Spondyloarthritis (AxSpA), Psoriatic Arthritis, Arthritis, and Psoriasis.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Nottingham, ENG, United Kingdom
Other Locations
Dm, Stoke-on-trent, ENG, United Kingdom
Stafford, ENG, United Kingdom
Exeter, ENG, United Kingdom
St. George's, Guy's And St. Thomas' NHS Foundation Trust, Epsom And St. Helier University Hospitals NHS Trust, Stepping Hill Hospital, Hexham, Synexus Thames Valley Dedicated Research Site, Oxford, St. James's University Hospital, Manchester, ENG, United Kingdom
Haywood, SCT ST67AG, United Kingdom
Keele, ENG, United Kingdom
London, ENG, United Kingdom
Bath, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2025
Intervention Type: Drug
Study Drugs: Ixekizumab, Adalimumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

52 Total Publications

Sexual function in axial spondyloarthritis: a systematic review and meta-analysis.
Sexual function in axial spondyloarthritis: a systematic review and meta-analysis.
Journal: Rheumatology (Oxford, England)
Published: May 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Packham's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile